Clinical Trial

HFpEF Phenotyping With Echo, Clinical, and Biomarkers

Study acronym: The EPIC-HFpEF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The EPIC-HFpEF registry is a nationwide Italian study that follows people with a specific type of heart failure called HFpEF. About 500 patients will be enrolled from several specialized hospitals and monitored for up to two years, without changing their usual treatment. The goal is to better understand this complex condition by identifying different patient "types" based on clinical features, heart imaging, and blood markers. Researchers will also look at how these groups are treated in real life and how their disease progresses over time. By doing this, the study aims to improve how doctors classify and manage HFpEF, moving toward more personalized and effective care for patients in the future.
Trial Details
NCT Number NCT07642921
Lead Sponsor University Of Perugia
Collaborators: Azienda Ospedaliera di Perugia, Ospedale Le Scotte, University of Foggia
Conditions Heart Failure With Preserved Ejection Fraction (HFPEF)
Enrollment 500 participants
Start Date 2026-06-02
Primary Completion 2027-06-30 (estimated)
Study Completion 2029-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-11